P/E ratio for HealthEquity (HQY)
P/E ratio as of April 2025 (TTM): 534
According to HealthEquity's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 534.118. At the end of 2022 the company had a P/E ratio of -88.1.
P/E ratio history for HealthEquity from 2014 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -88.1 | -86.07% |
| 2021 | -632 | -141.05% |
| 2020 | > 1000 | 1729.35% |
| 2019 | 84.2 | 52.4% |
| 2018 | 55.2 | -11.22% |
| 2017 | 62.2 | -33.98% |
| 2016 | 94.2 | 1.49% |
| 2015 | 92.9 | -377.34% |
| 2014 | -33.5 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | 15.3 | -97.13% | 🇺🇸 USA |
 | 8.18 | -98.47% | 🇺🇸 USA |
 | 24.5 | -95.41% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.